Ernesto Bertarelli

Ernesto Bertarelli is a Swiss entrepreneur whose current business interests include Bertarelli Partners and B-FLEXION, a private, entrepreneurial investment firm that oversees growth-oriented operating businesses and asset managers. In 1996, Ernesto was appointed CEO of Serono S.A., the bio-pharma business grown over the course of three generations by his family. Under his leadership, Serono accelerated its move from pharmaceuticals to biotechnology, was listed on the New York Stock Exchange and tripled its revenues. In 2007, Serono was sold to Merck KGaA.

Ernesto is a Chair of the Bertarelli Foundation, which is active in neuroscience research and marine conservation and science and is a Co-Founder of the Campus Biotech life sciences hub in Geneva. He is a member of Harvard Medical School’s Board of Fellows, of the Ecole Polytechnique fédérale de Lausanne’s Strategic Advisory Board, and of Harvard Business School’s Board of Dean’s Advisors. Between 2002 and 2009, Ernesto served as a board director of UBS AG.